In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of drug discovery.

Payments still power scale. But its updated draft red herring prospectus (UDRHP) shows that PhonePe’s monetisation story lies ...

Discover how researchers are overcoming the limitations of the undruggable target in drug discovery using novel approaches ...

Iran has approved more than 600 foreign investment applications worth nearly $17 billion since the start of the current ...

While AI accelerates change, the core principles of brand building remain unchanged: brands must be relevant, differentiated, ...

With five major educational institutions calling Mitchell home, there are always new programs to launch, student achievement ...

Join James Cropper for this exclusive webinar with Dr. Mandy Clement and Dale Brosius as they explore the trends driving ...

Discusses Integrated Prefillable Syringe Systems to Streamline Drug Development and Reduce Complexity February ...

Snap-on Incorporated ( SNA) Q4 2025 Earnings Call February 5, 2026 10:00 AM EST Good morning, and welcome to the Snap-on Inc.

This transformation is being driven by the integration of artificial intelligence (AI) across production, transmission, and ...

Building trust-centric AI workplaces with a clear charter—trust, transparency, augmentation, agency, equity, and source ...

A UT chemist says it is now time to develop tests for microplastics, similar to tests for other toxic threats.